Mar 26 2010
BIOTRONIK SE & Co. KG, a leading manufacturer of implantable cardiac
devices and pioneer of wireless remote monitoring technologies, today
announced the first implantations of the Lumax DX System, a novel
single-chamber ICD concept.
“BIOTRONIK once again sets standards in the diagnosis and treatment of
atrial fibrillation”
The Lumax 540 VR-T DX single-chamber ICD and the specially designed Linoxsmart
S DX right ventricular lead with floating atrial dipole provide
physicians with complete diagnostic information not only from the right
ventricle, as in regular single-chamber ICDs, but also from the right
atrium, including high resolution online IEGMs.
The additional atrial information can be used for advanced
discrimination of supraventricular tachycardias (SVTs) to avoid
inappropriate ICD shock therapies and for diagnostic purposes for early
detection of atrial arrhythmias, including atrial fibrillation (AF), to
reduce the risk of stroke.
World’s first and only single-chamber ICD designed for early
detection and diagnosis of AF
After receiving the CE mark, the first Lumax DX Systems were
successfully implanted simultaneously at six hospitals across Europe
during the third week of March.
The unique Lumax DX System provides patients at risk of sudden cardiac
death with a single-chamber ICD system that provides protection and
reduces risk. “The immediate information about atrial arrhythmias, even
when asymptomatic, allows me to detect and treat AF early and minimize
associated risks such as inappropriate therapies and stroke. Also, I can
monitor the success of my AF therapies remotely with BIOTRONIK Home
Monitoring® and contact the patient whenever needed,” said
Dr. Alexander Schirdewan from the Charité Campus Benjamin Franklin in
Berlin, Germany, Coordinating Clinical Investigator of the Linoxsmart
S DX master study, after the first implantation on March 18.
Lumax 540 VR-T DX uses the advanced BIOTRONIK SMART Detection algorithm
that analyzes the ventricular as well as the atrial heart rate to
appropriately discriminate supraventricular tachycardias from
ventricular tachycardias and thereby reduce the number of inappropriate
therapies and ensure that a shock is only delivered when absolutely
required. “So far, single-chamber ICDs were limited to ventricular
information for the discrimination of SVTs. The SMART algorithm also
uses the additional information from the atrium and has proven reliable
sensitivity and high specificity in dual-chamber ICDs, and now I can
offer this technology to my single-chamber ICD patients too,” said Prof.
Dr. Antonio Curnis from Spedali Civili in Brescia, at the University of
Brescia in Italy after the first implantation of the DX system on March
16.
Prof. Dr. Curnis was the principal investigator of the Italian ADAMO
registry that already proved the high sensitivity and specificity of the
SMART algorithm in a similar BIOTRONIK ICD system.
Combined with the clinically proven, fully mobile BIOTRONIK Home
Monitoring®, Lumax 540 VR-T DX is the world’s first and only
single-chamber ICD which wirelessly transmits all required patient and
device data, including IEGM Online HD® for early detection of
ventricular and atrial rate disorders and to perform complete remote
follow-ups.
Source BIOTRONIK SE & Co. KG